Ocular Therapeutix Balance Sheet - Quarterly (NASDAQ:OCUL)

Add to My Stocks
$6.14 $0.06 (0.97%) OCUL stock closing price Sep 17, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Ocular Therapeutix, and helps in stock analysis. As in our Ocular Therapeutix stock analysis, analyzing a company also involves looking at the company's assets and liabilities as given in its balance sheet, which can be used to measure financial performance. Quarterly results are typically accompanied with the company releasing financial statements. The Ocular Therapeutix balance sheet for 2018 Q2 shows total assets of $70.46M. The company has a asset turnover ratio of 0.04. Also see: Ocular Therapeutix revenue and Ocular Therapeutix operating cash flow for the same quarter.

View and download Ocular Therapeutix quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Marketable Securities----3M25.69M35.2M23.51M35.71M49.24M
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets1.22M1.25M1.45M-1.97M2.55M1.39M--1.28M
Total Current Assets
Property Plant & Equipment--15.81M---7.13M---
Accumulated Depreciation--5.34M---3.81M---
Net Property Plant & Equipment
Investment & Advances----------
Other Non-Current Assets----------
Deferred Charges----------
Deposits & Other Assets1.61M1.61M1.61M1.72M1.72M1.72M1.72M1.72M1.72M-
Total Assets
Notes Payable6.08M5.54M1.54M-1.35M1.8M1.8M---
Accounts Payable2.14M3.47M3.57M2.59M6.3M3.75M2.11M1.68M1.61M2.06M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses3.68M3.6M4.31M4.35M4.37M4M4.63M2.79M2.34M2.77M
Income Taxes Payable----------
Other Current Liabilities----------
Total Current Liabilities
Deferred Taxes/Income3.28M3.33M3.38M3.6M3.14M1.31M----
Convertible Debt----------
Long-Term Debt9.55M11.01M12.47M13.92M15.37M16.82M14.09M11.77M12.99M14.2M
Non-Current Capital Leases----------
Other Long-Term Liabilities----------
Total Liabilities
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus310.56M300.21M263.4M260.08M256.61M253.81M225.88M223.34M221.89M220.18M
Retained Earnings-264.83M-251.03M-237.26M-224.16M-208.59M-189.9M-173.87M-161.05M-151.46M-140.01M
Treasury Stock----------
Other Liabilities------0.01M-0.01M---
Shareholders Equity45.73M49.18M26.14M35.92M48.02M63.9M52M62.29M70.44M80.17M
Total Liabilities & Shareholders Equity70.46M76.68M55.43M64.39M79.67M90.69M74.93M82.34M89.9M100.43M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Ocular Therapeutix historical stock prices and the current Ocular Therapeutix stock price can tell you how the stock price has moved, whereas the Ocular Therapeutix PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: An asset is a resource that a corporation like Ocular Therapeutix owns and has monetary significance. OCUL assets decreased from $76.68M in 2018 Q1 to $70.46M in 2018 Q2. Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: This item on the balance sheet implies the firm's, in this case Ocular Therapeutix's, legal obligations including loans, accounts payable, deferred revenue, accrued expenses and mortgages. The total liabilities for OCUL stock stand at $24.73M.

Ocular Therapeutix Balance Sheet - Key Ratios

Current ratio
Debt to equity ratio
Asset turnover ratio
Receivables turnover
Price to book ratio